Not provided
Not provided
Not provided
Not provided
Not provided
COVID-19 and re-organisation at the hospital
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A randomized controlled trial comparing wake therapy (single night) followed by bright light therapy to treatment as usual.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Chronobiological intervention | Experimental | Single night's wake therapy followed by bright light therapy for a week as add-on treatment to treatment as usual. |
|
| Control | Active Comparator | Treatment as usual including a private educational meeting in sleep hygiene. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Single night's wake therapy | Behavioral | Eligible patients are assisted in maintaining total sleep deprivation during one night |
|
| Measure | Description | Time Frame |
|---|---|---|
| MADRS-S score reduction of 50% | Montgomery Asberg Depression Rating Scale | One week |
| Measure | Description | Time Frame |
|---|---|---|
| MADRS-S score at discharge | Montgomery Asberg Depression Rating Scale | Participants will be followed at discharge, an expected average of 2-3 weeks |
| MADRS-S score at follow-up | Montgomery Asberg Depression Rating Scale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Steinn Steingrimsson, MD, PhD | Sahlgrenska University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sahlgrenska University Hospital | Gothenburg | Västra Götaland County | Sweden |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Bright light | Device | Bright light according to patients´ own circadian rhythm each morning for a week. |
|
| Treatment as usual - inpatient care | Other | All patients are admitted due to severe depression and are under observation and most receive antidepressive medication and if necessary anxiolytic/antipsychotic medication. |
|
| Informative meeting | Other | A short sleep hygiene consultation. |
|
| Treatment as usual - medicine | Drug | Since all patients are admitted due to a severe mental illness, they will receive medication according to indication. Most patients have already tried more than one antidepressant at the time of admission. In cases of severe anxiety, anxiolytics are prescribed but this is kept to a minimum. |
|
| 10-14 weeks |
| ISI score score at discharge | Insomnia Severity Index - Self administered scale of sleep quality | Participants will be followed at discharge, an expected average of 2-3 weeks |
| ISI score score at follow-up | Insomnia Severity Index - Self administered scale of sleep quality | 10-14 weeks |
| ISI score reduction of 50% | Insomnia Severity Index - Self administered scale of sleep quality | One week |
| Length of stay | Patients will be followed up 10-14 weeks after discharge and the total number of days in inpatient services calculated. | The number of days between admission and discharge |
| Re-admission | 10-14 weeks |
| CGI score | Clinical global impression | One week |
| CGI score | Clinical global impression | 10-14 weeks |
| Medication use | The use of antidepressants, anxiolytics or other psychiatric medication will be registered at follow-up. The number of patients using more than one medication and the dosage will be compared. | 10-14 weeks |